Evercore Wealth Management’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-13,158
| Closed | -$2K | – | 944 |
|
|
2017
Q3 | $2K | Hold |
13,158
| – | – | ﹤0.01% | 885 |
|
|
2017
Q2 | $4K | Hold |
13,158
| – | – | ﹤0.01% | 921 |
|
|
2017
Q1 | $5K | Hold |
13,158
| – | – | ﹤0.01% | 893 |
|
|
2016
Q4 | $4K | Hold |
13,158
| – | – | ﹤0.01% | 915 |
|
|
2016
Q3 | $7K | Hold |
13,158
| – | – | ﹤0.01% | 912 |
|
|
2016
Q2 | $9K | Hold |
13,158
| – | – | ﹤0.01% | 865 |
|
|
2016
Q1 | $9K | Hold |
13,158
| – | – | ﹤0.01% | 818 |
|
|
2015
Q4 | $9K | Hold |
13,158
| – | – | ﹤0.01% | 871 |
|
|
2015
Q3 | $19K | Hold |
13,158
| – | – | ﹤0.01% | 756 |
|
|
2015
Q2 | $23K | Hold |
13,158
| – | – | ﹤0.01% | 773 |
|
|
2015
Q1 | $22K | Hold |
13,158
| – | – | ﹤0.01% | 771 |
|
|
2014
Q4 | $4K | Hold |
13,158
| – | – | ﹤0.01% | 815 |
|
|
2014
Q3 | $3K | Hold |
13,158
| – | – | ﹤0.01% | 907 |
|
|
2014
Q2 | $4K | Hold |
13,158
| – | – | ﹤0.01% | 938 |
|
|
2014
Q1 | $5K | Hold |
13,158
| – | – | ﹤0.01% | 868 |
|
|
2013
Q4 | $3K | Hold |
13,158
| – | – | ﹤0.01% | 823 |
|
|
2013
Q3 | $3K | Hold |
13,158
| – | – | ﹤0.01% | 942 |
|
|
2013
Q2 | $3K | Buy |
+13,158
| New | +$3.06K | ﹤0.01% | 775 |
|
Evercore Wealth Management's AXN Position: Q4 2017 in Review
Evercore Wealth Management sold out of Aoxing Pharmaceutical Company Inc. (AXN) in Q4 2017, closing a stake of 13,158 shares — an estimated $2K sold.
Evercore Wealth Management first reported a position in AXN in Q2 2013 and held it in 18 quarters. The position peaked at $23K in Q2 2015. 0 funds tracked by Wall St. Rank hold AXN as of Q4 2017.
- Evercore Wealth Management reported no remaining Aoxing Pharmaceutical Company Inc. position as of Q4 2017 after selling out during the quarter.
- Evercore Wealth Management sold 13,158 Aoxing Pharmaceutical Company Inc. shares in Q4 2017, an estimated $2K.
- Evercore Wealth Management first reported a position in Aoxing Pharmaceutical Company Inc. in Q2 2013 and held it in 18 quarters.
- Evercore Wealth Management's Aoxing Pharmaceutical Company Inc. position peaked at $23K in Q2 2015.
- 0 funds tracked by Wall St. Rank held Aoxing Pharmaceutical Company Inc. as of Q4 2017.
Based on Evercore Wealth Management's 13F filing for Q4 2017, filed 13 Feb 2018.